[1]李可 田进文 邓珏琳.老年高血压的临床诊治研究进展[J].心血管病学进展,2019,(9):1208-1211.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.006]
　LI Ke,TIAN Jinwen,DENG Juelin.Diagnosis and Treatment in Elderly Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):1208-1211.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.006]
点击复制

老年高血压的临床诊治研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年9期
页码:
1208-1211
栏目:
主题综述
出版日期:
2019-12-25

文章信息/Info

Title:
Diagnosis and Treatment in Elderly Hypertension
作者:
李可 田进文 邓珏琳
 (解放军总医院海南医院心血管内科,海南 三亚,572013)
Author(s):
LI Ke;  TIAN Jinwen;  DENG Juelin
(Hainan Hospital of Chinese Peoples Liberation Army General Hospital, Sanya 572013, Hainan, China)
关键词:
老年; 高血压; 药物治疗
Keywords:
Geriatric;  Hypertension;  Drug treatment
DOI:
10.16806/j.cnki.issn.1004-3934.2019.09.006
摘要:
老年人群高血压发病率随年龄的增长升高。由于年龄增长导致血管重塑和血管功能变化，以及压力反射调节和体液调节的病理生理变化，老年高血压有其自身的发病特点和临床特征。现着重探讨中国老年人高血压的诊治研究进展。
Abstract:
The incidence of hypertension in the elderly increased with age. Due to the changes of vascular remodeling and vascular function caused by age, as well as the pathophysiological changes of baroreflex regulation and humoral regulation, senile hypertension has its own pathogenic and clinical characteristics. This paper focuses on the research progress in the diagnosis and treatment of hypertension in the elderly in China

参考文献/References:


[1]中国老年医学学会高血压分会,国家老年疾病临床医学研究中心中国老年心血管病防治联盟.中国老年高血压管理指南2019[J].中华老年多器官疾病,2019,18(2):81-106.

[2]中国高血压防治指南修订委员会,刘力生,吴兆苏,等.中国高血压防治指南[J].中国心血管病杂志,2019,24(1):24-56.

[3]Kario K, Pickering TG, Umeda Y,et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study[J]. Circulation,2003,107(10):1401-1406.

[4]Staessen JA, Ga sowski J,Wang JG, et al.Risk of untreated and treated isolated systolic hypertension in the early: meta-analysis of outcome trials[J]. Lancet,2000,335(9207):865-872.

[5]Wang JG, Staessen JA,Gong L,et al. For the Systolic Hypertension in China(Syst-China) Collaborative Group.Chinese trial on isolated systolic hypertension in the elderly[J]. Arch Intern Med,2000,160(2):211-220.

[6]Gong L, Zhang W,Zhu Y, et al .Shanghai trial of nifedipine in the elderly(STONE) [J]. J Hypertens,1996,14(10):1237-1245.

[7]SPRINT Research Group,Wright JT Jr,Williamson JD,et al.A randomized trial of intensive versus standard blood-pressure Control[J].N Engl J Med,2015,373(22):2103-2116.

[8] Lonn EM,Bosch J,López-Jaramillo P,et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease[J].N Engl J Med,2016,374(21):2009-2020.

[9] 陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,36(6):662-665.

[10]Brunstrm M,Carlberg B.Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses[J].BMJ,2016,352: i717.

[11] Thomopoulos C,Parati G,Zanchetti A. Effects of blood-pressure lowering treatment on outcome incidence in hypertension: 10-should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials[J]. J Hypertens,2017,35(5):922-944.

[12] Emdin CA,Rahimi K,Neal B,et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis[J].JAMA,2015,313(6):603-615.

[13]孙刚,黄冠华.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,37(2):201-203.

[14]Williamson JD,Supiano MA,Applegate WB,et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥75 years: a randomized clinical trial[J]. JAMA,2016,315(24):2673-2682.

[15]Liu L,Wang Z,Gong L,et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature[J]. Hypertens Res,2009,32(11):1032-1040.

[16] Zheng Y,Cai GY,Chen XM,et al. Prevalence,awareness,treatment,and control of hypertension in the non-dialysis chronic kidney disease patients[J]. Chin Med J (Engl),2013, 126(12) :2276-2280.

[17]He FJ,Li J,Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials[J]. BJM,2013,4: f1325.

[18] Kovesdy CP,Bleyer AJ,Molnar MZ,et al. Blood pressure and mortality in U. S. Veterans with chronic kidney disease: a cohort study[J]. Ann Intern Med,2013,159(4):233-242.

[19] Weiss JW,Peters D,Yang X,et al. Systolic BP and mortality in older adults with CKD[J]. Clin J Am Soc Nephrol,2015,10(9):1553-1559.

相似文献/References:

[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
　SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(9):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
　FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(9):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
　CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(9):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
　ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
　ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
　HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(9):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
　ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(9):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]司晓云 周纬 谌晶晶 莫显刚 王龙 段小容.希氏束起搏与右室心尖部起搏对老年患者心功能影响的对比分析[J].心血管病学进展,2019,(7):1052.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.022]
　SI Xiaoyun ZHOU W eiSHEN JingjingMO XiangangWANG LongDUAN Xiaorong.A Comparative Study of Cardiac Function between Hirschner Bundle Pacing and Right Ventricular Aapex Pacing in Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(9):1052.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.022]
[9]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[10]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
　LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[11]侯利莎 葛宁 赵艳莉 张蒙 谢冬梅 高浪丽 岳冀蓉 郑玉霞.老年营养风险指数对老年高血压住院患者发生谵妄的预测价值[J].心血管病学进展,2020,(7):765.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.022]
　HOU Lisha,GE Ning,ZHAO Yanli,et al.Value of Geriatric Nutritional Risk Index in Predicting Risk of Delirium among Elderly Hypertension Patients[J].Advances in Cardiovascular Diseases,2020,(9):765.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.022]

更新日期/Last Update: 2020-02-06